1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$51.34 $0.06 (0.1%) 25 March 2026 at 7:00:00 am AEDT

Moderna Chart and Price Data

About Moderna

Last updated 25-03-2026, 07:00:00am AEDT
Current Price $51.34
Change $0.06 (0.1%)
Close Price $51.34
Open Price $50.44
Bid $51.35
Ask $51.80
Day Range $50.34 - $52.68
Year Range $22.28 - $59.55
Volume 4,804,763
Average Volume 11,296,397
Market Cap $20,252,471,900.00
Earnings Per Share $-7.26

Moderna (NASDAQ: MRNA)
Latest News

Chalice Mining share price value and growth ASX shares
Cheap Shares

Macquarie (ASX:MQG) picks best ASX stocks to buy for 2021 post-COVID recovery

| Brendon Lau

News of another promising COVID‐19 vaccine pushed the market higher but the best stocks to buy for 2021 won’t be…

Read more »

Share Market News

ASX 200 on watch after study shows Moderna's COVID-19 vaccine is 94.5% effective

| James Mickleboro

The ASX 200 will be on watch today after Moderna released even stronger phase 3 results for its COVID-19 vaccine...

Read more »

person receiving coronavirus vaccine injection into the arm
International Stock News

3 reasons Pfizer and BioNTech will have coronavirus vaccine data before Moderna

| Brian Orelli, PhD

Different clinical trial designs gives the duo an advantage, but coming in first isn't the end goal for vaccine makers.

Read more »

doctor giving little boy vaccine injection in his arm
International Stock News

Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

| Brian Orelli, PhD

The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

Read more »

doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
International Stock News

The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

| Keith Speights

Hint: It's not Moderna.

Read more »

International Stock News

What if more than one company wins the coronavirus vaccine race?

| Alex Carchidi

The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the…

Read more »

CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
International Stock News

Coronavirus vaccine race: 7 key things you'll want to know

| Keith Speights

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

Read more »

Patient wearing mask gets COVID vaccine injection
International Stock News

AstraZeneca coronavirus vaccine clinical trial paused

| Brian Orelli, PhD

One participant fell ill, but the connection to treatment with AZD122 is unclear.

Read more »

International Stock News

How to invest in coronavirus vaccine stocks

| Keith Speights

Just follow these three simple steps.

Read more »

Blue gloved hands holding up vials with covid vaccine labels
International Stock News

In the race for a coronavirus vaccine, can there be multiple winners?

| Adria Cimino

Demand says we may need several players crossing the finish line.

Read more »

International Stock News

How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days

| Brian Orelli, PhD

Biotech company Moderna got a little help from Amazon's AWS in the race for a coronavirus vaccine.

Read more »

International Stock News

Everything you need to know about the coronavirus vaccine race

| Keith Speights

Here are your answers to the questions that matter the most about COVID-19 vaccines in development

Read more »

Profile

since

Note